Search Results for: David Sinclair

Weekly reads: reprogramming aging, astrocytes, cartilage, ChatGPT

Let’s start with a couple of new pieces on in vivo reprogramming. The idea here is to do something like making iPS cells but doing it inside organisms and not quite pushing cells all the way back to pluripotency. Just younger, healthier cells. Why do that? The goal is to achieve a kind of anti-aging […]

Weekly reads: reprogramming aging, astrocytes, cartilage, ChatGPT Read More »

Weekly reads: Doritos mice, in vivo reprogramming, iPS cells for diabetes, MYC, uterine stem cells

Doritos and mice

What do you get when you mix Doritos and mice? Apparently see-through mice. Of course, it’s not that simple but the finding related to Doritos has captured people’s attention. Doritos and mice I’ve had several people ask me about the Doritos orange dye and “transparent mice” paper. It is interesting that the orange dye in

Weekly reads: Doritos mice, in vivo reprogramming, iPS cells for diabetes, MYC, uterine stem cells Read More »

Defining epigenetic reprogramming, cellular reprogramming & rejuvenation

epigenetic reprogramming

Epigenetic reprogramming is a term used in cell biology that is increasingly ending up in news stories too. Unfortunately, some folks, especially in the cellular rejuvenation and anti-aging space, are getting this term and other things confused. Just to start off, epigenetic reprogramming does not specifically mean cellular rejuvenation. The goal of today’s post is

Defining epigenetic reprogramming, cellular reprogramming & rejuvenation Read More »

Some surprises from new analysis of Altos Labs papers

Altos Labs

Altos Labs is an intriguing multi-institution experiment in so-called rejuvenation research all rolled into one biotech. This relatively new entity headquartered in California has multiple Nobel laureates in the biomedical field in leadership. Even more importantly it has a large group of great researchers leading its individual research labs. This all leads to high expectations,

Some surprises from new analysis of Altos Labs papers Read More »